1. Home
  2. XOMA vs GHY Comparison

XOMA vs GHY Comparison

Compare XOMA & GHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • GHY
  • Stock Information
  • Founded
  • XOMA 1981
  • GHY 2012
  • Country
  • XOMA United States
  • GHY United States
  • Employees
  • XOMA N/A
  • GHY N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • GHY Trusts Except Educational Religious and Charitable
  • Sector
  • XOMA Health Care
  • GHY Finance
  • Exchange
  • XOMA Nasdaq
  • GHY Nasdaq
  • Market Cap
  • XOMA 457.6M
  • GHY 539.8M
  • IPO Year
  • XOMA N/A
  • GHY N/A
  • Fundamental
  • Price
  • XOMA $39.01
  • GHY $12.65
  • Analyst Decision
  • XOMA Strong Buy
  • GHY
  • Analyst Count
  • XOMA 2
  • GHY 0
  • Target Price
  • XOMA $69.50
  • GHY N/A
  • AVG Volume (30 Days)
  • XOMA 55.5K
  • GHY 184.8K
  • Earning Date
  • XOMA 11-06-2025
  • GHY 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • GHY 10.58%
  • EPS Growth
  • XOMA N/A
  • GHY N/A
  • EPS
  • XOMA N/A
  • GHY N/A
  • Revenue
  • XOMA $44,952,000.00
  • GHY N/A
  • Revenue This Year
  • XOMA $88.91
  • GHY N/A
  • Revenue Next Year
  • XOMA $13.80
  • GHY N/A
  • P/E Ratio
  • XOMA N/A
  • GHY N/A
  • Revenue Growth
  • XOMA 194.98
  • GHY N/A
  • 52 Week Low
  • XOMA $18.35
  • GHY $10.24
  • 52 Week High
  • XOMA $39.92
  • GHY $11.92
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 66.59
  • GHY 21.33
  • Support Level
  • XOMA $34.42
  • GHY $12.71
  • Resistance Level
  • XOMA $39.92
  • GHY $13.26
  • Average True Range (ATR)
  • XOMA 1.88
  • GHY 0.12
  • MACD
  • XOMA 0.01
  • GHY -0.06
  • Stochastic Oscillator
  • XOMA 90.81
  • GHY 0.38

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About GHY PGIM Global High Yield Fund Inc.

PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.

Share on Social Networks: